
Alpha-Lipoic Acid: Food Sources, the Evidence, and What It Does in Your Mitochondria
, by The ENERGYbits Team, 44 min reading time

, by The ENERGYbits Team, 44 min reading time
Alpha lipoic acid foods explained: where lipoyllysine occurs, why diet gives tiny amounts versus supplements, what trials show, and key safety cautions.
Search for alpha lipoic acid foods and you will find lists of spinach, broccoli and organ meats alongside a supplement aisle selling 600 mg capsules. Those two things are not the same, and the gap between them is the most useful thing to understand. This guide covers what lipoic acid does inside mitochondria, what food really supplies, what the clinical trials on supplements show (and where they fall short), and the safety points worth knowing before you buy a bottle.
ENERGYbits® • Mitochondria
Quick Answer
Alpha-lipoic acid occurs in food only in tiny, protein-bound amounts. Foods supply it as lipoyllysine, mostly in organ meats such as kidney, heart and liver, with smaller amounts in vegetables like spinach and broccoli [1]. Supplements deliver 50 to 600 mg of free lipoic acid, which may be up to 1,000 times what a diet provides [1]. Your cells also make their own supply [2].
Alpha-lipoic acid (ALA), also called lipoic acid or thioctic acid, is a small sulfur-containing fatty acid. In most nutrition conversations it gets filed under "antioxidants," but that label undersells what it does in the body and oversells what we know about eating more of it.
Two forms matter. The R-form is the one your cells make and use. It is attached covalently to a lysine amino-acid residue on specific enzymes, where it works as a prosthetic group (a permanent working part of the enzyme) [1]. Most supplements contain a racemic mix of the R- and S-forms, and some products use the R-form alone. The distinction matters because the human multivitamin transporter handles R-lipoic acid selectively [19].
Quick Answer
Lipoic acid is a mitochondrial cofactor first and an antioxidant second. In humans, lipoate is a covalently bound cofactor for five enzyme complexes, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which sit at the center of cellular energy metabolism [2]. The free form sold as a supplement has separate antioxidant and signaling activities studied in cells and animals [20].
It helps to keep three ideas apart as you read the rest of this article: bound lipoate (the cofactor inside your enzymes), lipoyllysine (what that cofactor looks like in food protein), and free lipoic acid (what a capsule delivers). Most confusion online comes from treating them as one thing.
Your mitochondria turn fuel into usable energy through a sequence of reactions. Two of the gatekeeping steps depend on lipoate. The pyruvate dehydrogenase complex (PDH) converts pyruvate, a product of glucose breakdown, into acetyl-CoA, which feeds the citric acid cycle. The alpha-ketoglutarate dehydrogenase complex (KGDH) converts alpha-ketoglutarate to succinyl-CoA inside that cycle [1].
Inside each complex, lipoate is bound to a lysine on the E2 subunit and acts as a "swinging arm" that carries reaction intermediates between active sites [4]. Without lipoylation, those complexes do not work. Lipoate also serves the branched-chain ketoacid dehydrogenase, the 2-oxoadipate dehydrogenase and the glycine cleavage system, which links to folate metabolism and nucleic acid synthesis [1,2].
This is the point that most supplement marketing skips. Human mitochondria synthesize lipoate on site, building it from an octanoyl group derived from mitochondrial fatty acid synthesis, with an iron-sulfur enzyme called lipoic acid synthetase (LIAS) inserting the sulfur atoms [2]. The cofactor is assembled directly on the proteins that need it, rather than being delivered as a finished vitamin and attached afterward [4].
What the research says
Inherited defects in the lipoate pathway are rare and severe. A child with a LIAS mutation had neonatal-onset epilepsy, lactic acidosis and reduced pyruvate dehydrogenase activity, with a marked reduction of lipoamide on lipoylated proteins [3]. The Linus Pauling Institute notes that giving lipoic acid does not correct these enzyme defects [1]. For people without such mutations, there is no recognized dietary requirement for lipoic acid.
Making lipoate also uses upstream building blocks, and the enzyme chain it serves relies on other nutrients. PDH, for example, also depends on thiamin, riboflavin, niacin and pantothenic acid. For a food-first view of those partners, see our guide to supporting mitochondria with food and the deeper look at how cells produce energy.
In food, lipoic acid is not floating around free. It is covalently bound to lysine within proteins, as lipoyllysine [1]. That fits the biology: lipoate lives on the mitochondrial enzyme complexes, so foods with abundant mitochondria and metabolic activity tend to carry more of it.
Quick Answer
The richest foods are animal organs; vegetables carry less. Lipoyllysine is highest in kidney, heart and liver, at roughly 1 to 3 micrograms per gram dry weight, and lower, around 0.5 micrograms per gram dry weight, in tomatoes, peas and Brussels sprouts [1]. Spinach and broccoli are commonly named as vegetable sources, though the Linus Pauling Institute gives no figure for them [1].
Because ENERGYbits makes spirulina and chlorella, we looked for published lipoic acid or lipoyllysine measurements in these algae and did not find reliable ones. So we are not going to tell you spirulina is a source of alpha-lipoic acid. All living cells with PDH and KGDH contain some bound lipoate, so algae almost certainly contain some, but that is an inference about biology, not a measured nutrient value, and nobody should buy algae for this reason.
What spirulina does offer, as a whole food, is protein, B vitamins, minerals, chlorophyll and phycocyanin. Our overview of nutrient-dense foods covers that profile. The fair framing is that whole foods support the broad nutrient environment your mitochondria work in, not that any one food replaces a specific cofactor.
Supplement labels for ALA typically range from 50 to 600 mg [1]. Clinical trials have used 600, 1,200 or 1,800 mg per day by mouth, and 600 mg per day intravenously [9,10]. Compare that with the food figures above.
Quick Answer
A supplement dose can be hundreds to thousands of times what food supplies. The Linus Pauling Institute estimates supplement amounts may be as much as 1,000 times greater than dietary intake [1]. Our own illustration: even 100 g of dry tissue at the high end of 3 µg per g gives 0.3 mg (calculated), while a typical trial dose is 600 mg. Food has not been shown to raise free lipoic acid in blood or cells [1].
What the research says
Free lipoic acid is absorbed quickly. In a crossover study of 24 healthy adults taking 600 mg doses, time to peak concentration was about 20 to 30 minutes, and tablet forms reached 64 to 79 percent of the exposure of an oral solution for the R-enantiomer [7]. Food intake lowered peak plasma levels by about 30 percent and total exposure by about 20 percent in earlier work, which is why trials and labels often advise taking it on an empty stomach [1][8]. Food-bound lipoyllysine behaves differently: it must be released from protein first, and eating it has not been found to produce detectable increases in free lipoic acid [1].
This is why you should be skeptical of any claim that "eating ALA-rich foods" reproduces what is seen in supplement trials. It does not, because the exposure is not comparable. It is equally why the supplement literature cannot be borrowed to promote vegetables. Each stands on its own evidence.
None of this makes spinach, broccoli or organ meats unhelpful. They contribute fiber, folate, vitamin K, iron and other nutrients, and a diet built around them is a sensible foundation for mitochondrial health. The lipoyllysine they carry is simply a minor, unquantified bonus, and not a reason to choose them.
The strongest human data for supplemental ALA come from people with diabetic peripheral neuropathy, a nerve condition causing pain, burning and numbness in the feet. This research is conducted under medical supervision with defined doses, and it should not be read as general advice for healthy people.
A 2012 meta-analysis of randomized trials found a pooled reduction in Total Symptom Score of 2.26 standardized units favoring ALA, with the intravenous 600 mg per day for 3 weeks route judged clinically relevant. It was unclear whether the 3 to 5 week oral benefit at doses above 600 mg was clinically relevant [12]. A 2026 Bayesian network meta-analysis of nine randomized trials concluded the intravenous route ranked best for symptoms and signs, after sensitivity analyses removed an apparent advantage of sequential therapy that turned out to be an artifact of within-study bias [13].
What the research says
A 2026 critical review summarized the picture this way: ALA consistently improves short-term symptoms across several randomized trials, while the long-term evidence for stabilizing nerve function is very limited and inconclusive, with NATHAN 1 showing only a borderline effect on its primary measure [14]. Mixed results, heterogeneous trials and different routes of administration mean this is promising but unsettled evidence, and it applies to a specific patient group.
If you have diabetic neuropathy, ALA is a conversation for your endocrinologist or neurologist. Dosage, route and monitoring belong in that setting, particularly because of the blood-sugar effects covered below. If you do not have the condition, none of these results show that ALA prevents it, and we would not suggest otherwise.
Beyond neuropathy, researchers have asked whether ALA improves glycemic control and other markers. The results are modest and inconsistent.
| Analysis | What it found | Main limitation |
|---|---|---|
| Rahimlou 2019, 41 trials | Lower fasting glucose (-6.57), HbA1c (-0.35), TNF-alpha, IL-6 and CRP; no effect on insulin or HOMA-IR [15] | Trial quality varied: 19 good, 6 fair, 16 poor |
| Mahmoudi-Nezhad 2021, 28 trials, 1,016 participants | Lower insulin and HOMA-IR; no change in glucose or HbA1c [16] | Heterogeneity by dose, duration, health status |
| Kucukgoncu 2017, 10 trials | About 1.27 kg more weight loss than placebo; BMI 0.43 kg/m² lower [17] | Short term; no dose relationship; authors call for more research |
Note the contradiction in the first two rows. One analysis found a lower HbA1c and no effect on insulin; the other found lower insulin and no effect on HbA1c. That is typical of a literature made of small, varied trials, and it is a reason for caution rather than confidence.
Quick Answer
Supplemental ALA shows small, inconsistent effects on blood sugar and weight. Pooled trials report modest changes in some glycemic markers, but the analyses disagree on which ones [15,16]. A weight-loss meta-analysis found about 1.27 kg more loss than placebo over short periods [17]. These effects are small, come from supplements at doses far above food levels, and do not support using ALA as a weight or diabetes treatment.
For readers interested in metabolic health, the better-evidenced levers remain sleep, physical activity, protein and fiber intake, and clinician-guided management of glucose. ALA, if used at all, is an adjunct a clinician may consider, not a substitute.
Short-term oral use of ALA is generally well tolerated in trials, but "well tolerated" has limits. Reported effects include nausea, vomiting, vertigo, abdominal pain, allergic skin reactions and, at 1,200 mg per day, malodorous urine [1,10]. These are the main points to discuss with a clinician before starting.
Lipoic acid and biotin are structurally similar. The human multivitamin transporter handles both, and R-lipoic acid is a physiological substrate of it [19]. In a 28-day rat study, daily lipoic acid injections lowered the activity of two biotin-dependent enzymes, pyruvate carboxylase and beta-methylcrotonyl-CoA carboxylase, by 28 to 36 percent, and adding biotin restored normal activity [18]. It is not known whether oral or intravenous lipoic acid raises human biotin requirements [1]. For now the interaction is a plausible concern from animal and transport data, not a proven human deficiency.
Because lipoic acid may improve insulin-mediated glucose use, people taking insulin or oral glucose-lowering drugs may be at risk of hypoglycemia, and blood glucose should be monitored closely [1]. A single 600 mg dose showed no significant interaction with glyburide or acarbose in 24 healthy volunteers, but that does not cover long-term use in people with diabetes [1].
A rarer but serious concern is insulin autoimmune syndrome (IAS), which causes spontaneous low blood sugar. EFSA reviewed 49 published case reports in which IAS developed after ALA use; in every case it resolved within weeks to months after stopping [5]. EFSA concluded that ALA added to foods, including supplements, is likely to increase IAS risk in people with certain genetic polymorphisms who cannot readily be identified without testing, and that no safe threshold dose could be set. It found no publication linking naturally occurring food ALA to IAS [5]. If you notice unexplained shakiness, sweating or confusion with low glucose readings after starting ALA, seek medical care.
What the research says
IAS is uncommon. EFSA noted that its incidence in Europe is likely lower than the estimated 0.017 cases per 100,000 inhabitants reported in Japan in 2017 to 2018 [5]. Rarity is not the same as zero, and there is currently no practical way to screen for susceptibility ahead of time. This is the clearest example of why supplement-dose ALA and food-level lipoyllysine should not be treated as equivalent.
Thyroid concerns come up often in supplement guides. We could find only animal data: in obese mice, lipoic acid supplementation was associated with changes in thyroid hormone measures [21]. We did not find convincing human evidence of harm, so treat this as a precaution: if you take thyroid medication, tell your clinician before adding ALA so your labs can be interpreted properly. For pregnancy, the Linus Pauling Institute advises use only under strict medical supervision, and it discourages use while breastfeeding because safety is not established [1]. A toddler who swallowed four 600 mg tablets had seizures and acidosis before recovering, so keep supplements out of children's reach [1].
Quick Answer
For most healthy adults, food-first is the better default. There is no established dietary requirement for lipoic acid, your cells synthesize it, and food-level intake has not been linked with measurable benefit or harm [1,2,5]. Supplements may be considered by clinicians for specific conditions such as diabetic neuropathy, in which case dose, route and monitoring should be supervised.
A practical way to decide:
If you do use a supplement, the pharmacokinetic data suggest taking it away from meals for better absorption [1,7,8], and starting at a low dose to check tolerance. Choose products with third-party testing, and stop and seek care if you develop low-blood-sugar symptoms or a rash.
The most defensible nutrition advice for mitochondria is dull but reliable. Eat enough protein, because enzymes, including the lipoylated complexes, are made of it. Cover your B vitamins, iron, magnesium and other cofactors through varied whole foods. Include colorful plants for polyphenols and carotenoids. Sleep, move, and manage blood sugar. None of that is as exciting as a single molecule, yet it supports every enzyme in the chain, not one step of it.
Those cofactors are also where algae earn their place. Spirulina provides protein and a range of B vitamins and minerals in a very compact whole food; read our B12 explainer for a clear look at which B vitamins it does and does not provide, and the comparison with CoQ10 for another supplement-versus-food question. For the bigger picture of long-term cellular health, see healthspan versus lifespan and foods that support NAD.
Where ENERGYbits fits, and where it does not
ENERGYbits spirulina is a single-ingredient whole food: freshwater-grown, gently dried at low temperatures and third-party tested for purity and contaminants, with no fillers or additives. A full serving is 30 tablets of 250 mg each, or 7.5 g. It is a way to add protein, B vitamins, minerals, chlorophyll and phycocyanin to a food-first routine. It is not a source of lipoic acid that we can verify, and it is not a substitute for a clinician-directed ALA protocol. If you want to try spirulina alongside chlorella, see the ENERGYbits spirulina or the VITALITYbits spirulina and chlorella blend.
| Lipoyllysine in food | Algae as a whole food | Free ALA supplement | |
|---|---|---|---|
| Form | Protein-bound lipoyllysine [1] | Not characterized for lipoic acid in our review | Free R/S lipoic acid [1] |
| Typical amount | Micrograms per gram dry weight [1] | Unknown | 50 to 600 mg [1] |
| Raises free ALA in blood? | Not shown [1] | Not studied | Yes, transiently at 50 mg or more [1] |
| Human trial evidence | None identified for health outcomes [1] | Not for ALA | Neuropathy, mixed glycemic data [9-17] |
| Main cautions | Few known | Standard whole-food considerations | Hypoglycemia, biotin competition, IAS [1,5,18] |
| Main value | Part of a varied diet | Protein, B vitamins, minerals, pigments | Clinician-guided use in selected conditions |
The takeaway from the comparison is that these are three different tools. Using one to justify another leads to the wrong conclusions in both directions.
Evidence-first nutrition, weekly
Get one evidence-first article on algae, mitochondria and whole-food nutrition in your inbox each week, with the studies linked and the limits stated.
Join the newsletterKey takeaways
The phrase "alpha lipoic acid foods" suggests a shopping list, but the evidence points somewhere more modest. Lipoate is a vital working part of your mitochondrial enzymes, your body builds it itself, and the small amounts in food come bound to protein rather than as the free compound used in trials. Diets rich in whole foods are good for you for many reasons, and lipoyllysine is a minor one.
Supplemental ALA has a real research history, especially in diabetic neuropathy, but the results are mixed, the doses are pharmacological and the cautions are real. If you are considering it, involve a clinician, particularly if you use diabetes or thyroid medicines. If you are looking for a food-first way to support the nutrient environment your mitochondria depend on, a varied diet with enough protein, B vitamins and minerals, with whole foods like spirulina where they fit, is the sound place to start.
Lipoic acid occurs in food as protein-bound lipoyllysine. It is highest in animal kidney, heart and liver, and lower in vegetables such as spinach, broccoli, tomatoes, peas and Brussels sprouts [1]. Quantitative food data are limited, so exact amounts per serving are not well established, and no reliable chart exists.
Food supplies micrograms per gram of dry weight, about 1 to 3 in organ meats and about 0.5 in some vegetables [1]. Supplements deliver 50 to 600 mg of free lipoic acid, which the Linus Pauling Institute says may be as much as 1,000 times more than a diet provides [1].
There is no established requirement for dietary lipoic acid because human mitochondria synthesize it, using an enzyme called lipoic acid synthetase [2]. Inherited defects in that pathway are rare and severe, and supplements do not correct them [1,3]. For healthy people, eating a varied diet is sufficient.
Lipoate is a cofactor bound to lysine residues on mitochondrial enzyme complexes, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which feed the citric acid cycle [1,2]. Without it these complexes cannot work. That cofactor role is distinct from the antioxidant effects of free ALA in cells [20].
We could not find verified published measurements of lipoic acid or lipoyllysine in spirulina, so we do not claim that it is a source. Like all cells with energy-metabolizing enzymes, algae likely contain some bound lipoate, but that is an inference, not a measured nutrient value.
Evidence is mixed but suggests short-term symptom benefit. SYDNEY 2 showed greater symptom reduction at 600 mg per day over 5 weeks [10], while ALADIN III and NATHAN 1 showed less clear results [9,11]. A 2026 review calls long-term nerve-protection evidence inconclusive [14]. This is a decision for a clinician.
Results vary. One meta-analysis of 41 trials found lower fasting glucose and HbA1c [15], while another of 28 trials found lower insulin and insulin resistance with no change in glucose or HbA1c [16]. Because it may lower glucose, people on diabetes medicines should monitor closely [1].
A meta-analysis of 10 randomized trials found about 1.27 kg more weight loss than placebo and a 0.43 kg/m² lower BMI, with the authors calling it small, short term and in need of more research [17]. It is not a substitute for diet, activity or medical weight management.
Possibly. Lipoic acid and biotin are structurally similar and share a transporter [19]. In rats, lipoic acid lowered two biotin-dependent enzymes by 28 to 36 percent, and biotin restored them [18]. Whether oral ALA raises human biotin needs is not known [1].
It can, especially alongside insulin or glucose-lowering drugs, because it may improve insulin-mediated glucose use [1]. It has also been linked to insulin autoimmune syndrome: EFSA reviewed 49 case reports, all of which resolved after stopping ALA [5]. Report unexplained low glucose symptoms to a doctor.
We did not find convincing human evidence of thyroid harm. The available data we found were from animal studies, including a mouse study in which lipoic acid was associated with changes in thyroid hormone measures [21]. If you take thyroid medication, tell your clinician before starting ALA so labs can be interpreted correctly.
Pharmacokinetic work found that food lowered peak plasma levels by about 30 percent and total exposure by about 20 percent, so supplement guidance often suggests taking it about 30 minutes before a meal [1][8]. This applies to free ALA capsules, not to lipoyllysine in food.
R-lipoic acid is the form your body makes and the one that binds to enzymes and is selectively transported by the human multivitamin transporter [1,19]. Racemic ALA is a 50:50 mix of R and S forms and is common in supplements [7]. Which is better clinically is not settled.
The Linus Pauling Institute advises ALA use in pregnancy only under strict medical supervision and discourages use while breastfeeding because safety has not been established [1]. Food-level intake from a normal diet is not a concern. Ask your obstetrician or midwife before using any ALA supplement.
This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. ENERGYbits® products are whole-food supplements and are not intended to diagnose, treat, cure, or prevent any disease. Talk with your doctor before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a medical condition.